MiniMed Group, Inc. (MMED)

MiniMed Group, Inc. is trading at $18.28, down 5.04% on the session. The 50 day average sits at $20.15 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 43.8, which reads as weak, and MACD is bullish crossover. Volume is below average.

The nearest support is around $16.56 with resistance near $20.15, so that band frames the current range. Average daily movement is roughly $0.88, or about 4.8% of the share price, which is what any stop placement has to allow for. The overall health score of 42 out of 100 combines a trend score of 32, momentum of 51 and a risk score of 46.

MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform includes Automated Insulin Delivery (AID) systems for glucose sensing and automated insulin dosing and administration for glycemic control and Smart Multiple Daily Injection (MDI) systems for self-administering insulin by manual injections, which include InPen, Simplera Sync, or Guardian 4 sensor, and wraparound applications and services. It also offers CareLink, a software platform that provides support for person with diabetes, their caretakers, and HCPS. MiniMed Group, Inc. was founded in 1983 and is headquartered in Northridge, California. MiniMed Group, Inc. operates as a subsidiary of Medtronic plc.